Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-29 @ 12:06 AM
Study NCT ID:
NCT00706992
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2008-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2012-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-27
First Submit QC Date:
None
Study First Post Date:
2008-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-18
Results First Submit QC Date:
None
Results First Post Date:
2013-03-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-06
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED